Patent details

EP3028718 Title: TREATMENT OF MULTIPLE SCLEROSIS (MS) WITH CAMPATH-1H

Basic Information

Publication number:
EP3028718
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP151914918
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF MULTIPLE SCLEROSIS (MS) WITH CAMPATH-1H
French Title of Invention:
TRAITEMENT DE LA SCLEROSE EN PLAQUES (MS) PAR LE CAMPATH-1H
German Title of Invention:
BEHANDLUNG VON MULTIPLER SKLEROSE (MS) MIT CAMPATH-1H
SPC Number:

Dates

Filing date:
11/09/2007
Grant date:
23/03/2022
EP Publication Date:
08/06/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
23/03/2022
EP B1 Publication Date:
23/03/2022
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/09/2022
Expiration date:
11/09/2027
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
16/03/2022
 
 

Name:
Alcafleu Management GmbH & Co. KG
Address:
Lilienthalstrasse 4, 12529 Schönefeld OT Waltersdorf, Germany (DE)

Name:
Genzyme Corporation
Address:
50 Binney Street, Cambridge, MA 02142, United States (US)

Inventor

1

Name:
SACHSE, Andreas
Address:
Germany (DE)

2

Name:
MARGOLIN, David Harris
Address:
United States (US)

Priority

1

Priority Number:
844251 P
Priority Date:
13/09/2006
Priority Country:
United States (US)

2

Priority Number:
06090169
Priority Date:
14/09/2006
Priority Country:
European Patent Office (EPO) (EP)

Classification

IPC classification:
A61K 39/395; C07K 16/28;

Publication

European Patent Bulletin

Issue number:
202212
Publication date:
23/03/2022
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages